Tommasi selected to receive Best of Molecular Therapy Advances Award for 2026

Anna Tommasi’s paper, “Efficient Nonviral Integration of Large Transgenes into Human T Cells Using Cas9-CLIPT,” was chosen based on its novelty, innovation, and scientific significance. A member of the Saha lab, she will be formally presented with the award at the American Society of Gene and Cell Therapy’s annual meeting in May.